<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thrombopoietin (TPO), produced mainly in the liver, is a major regulator of platelet production </plain></SENT>
<SENT sid="1" pm="."><plain>Serum TPO levels are generally increased in <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of a 12-year-old boy with <z:hpo ids='HP_0011010'>chronic</z:hpo> severe <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> and <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Severe <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> was found at 9 months of age </plain></SENT>
<SENT sid="4" pm="."><plain>It was resistant to any treatment </plain></SENT>
<SENT sid="5" pm="."><plain>Studies on megakaryocytic colonies in vitro revealed that the marrow cells responded well to TPO and no plasma inhibitor was found </plain></SENT>
<SENT sid="6" pm="."><plain>Although hepatic function test results were <z:mpath ids='MPATH_458'>normal</z:mpath>, serum TPO levels in the patient (0.94 fmol/ml) were consistent with those in age-matched children (0.49-1.75 fmol/ml) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> requires individual evaluation before clinical trials with TPO </plain></SENT>
</text></document>